Skip to main content

Prevention of Cardiovascular Disease News (Page 17)

A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound

MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....

A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound

MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....

FDA Approves Yosprala (aspirin and omeprazole) for Secondary Prevention of Cardiovascular Disease in Patients at Risk for Aspirin-Associated Gastric Ulcers

MISSISSAUGA, Ontario, Sept. 15, 2016 /PRNewswire/ – Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, announced today that the U.S. Food and Drug...

FDA Approves Crestor to Reduce Stroke, Heart Attack Risk

Approval based on JUPITER study which evaluated Crestor in a previously unstudied population WILMINGTON, Del., Feb. 8 /PRNewswire-FirstCall/ – AstraZeneca today announced that the US Food and Drug...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Cardiovascular Risk Reduction, Cardiovascular Conditions and Disorders

Related drug support groups

atorvastatin, Lipitor, simvastatin, Crestor, rosuvastatin